These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21880714)

  • 1. Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells.
    Yamaguchi H; Yu T; Noshita T; Kidachi Y; Kamiie K; Yoshida K; Akitaya T; Umetsu H; Ryoyama K
    J Biol Chem; 2011 Oct; 286(42):36888-97. PubMed ID: 21880714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathione.
    Yamaguchi H; Yu T; Kidachi Y; Akitaya T; Yoshida K; Kamiie K; Noshita T; Umetsu H; Ryoyama K
    Biochimie; 2011 Jul; 93(7):1172-8. PubMed ID: 21539886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells: potential involvement of H-Ras downregulation.
    Yu T; Yamaguchi H; Noshita T; Kidachi Y; Umetsu H; Ryoyama K
    Toxicol Lett; 2010 Feb; 192(3):425-30. PubMed ID: 19958823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2.
    Vicker N; Su X; Lawrence H; Cruttenden A; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3263-7. PubMed ID: 15149687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
    Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.
    Su X; Lawrence H; Ganeshapillai D; Cruttenden A; Purohit A; Reed MJ; Vicker N; Potter BV
    Bioorg Med Chem; 2004 Aug; 12(16):4439-57. PubMed ID: 15265495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
    Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2.
    Yamaguchi H; Akitaya T; Yu T; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Ryoyama K
    Eur J Med Chem; 2011 Apr; 46(4):1325-30. PubMed ID: 21333409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3'-Substituted-1',2',4'-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their
    Markov AV; Sen'kova AV; Popadyuk II; Salomatina OV; Logashenko EB; Komarova NI; Ilyina AA; Salakhutdinov NF; Zenkova MA
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and optimization of MCF-7 cell line for screening selective inhibitors of 11beta-hydroxysteroid dehydrogenase 2.
    Kim CH; Cho YS
    Cell Biochem Funct; 2010 Aug; 28(6):440-7. PubMed ID: 20629036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid.
    Classen-Houben D; Schuster D; Da Cunha T; Odermatt A; Wolber G; Jordis U; Kueenburg B
    J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):248-52. PubMed ID: 19429429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.
    Yamaguchi H; Noshita T; Yu T; Kidachi Y; Kamiie K; Umetsu H; Ryoyama K
    Eur J Med Chem; 2010 Jul; 45(7):2943-8. PubMed ID: 20398972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and structural analysis of cofactor-protein interaction between NAD⁺ and 11β-hydroxysteroid dehydrogenase type 2.
    Yamaguchi H; Akitaya T; Yu T; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Ryoyama K
    J Mol Model; 2012 Mar; 18(3):1037-48. PubMed ID: 21667072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents.
    Tatsuzaki J; Taniguchi M; Bastow KF; Nakagawa-Goto K; Morris-Natschke SL; Itokawa H; Baba K; Lee KH
    Bioorg Med Chem; 2007 Sep; 15(18):6193-9. PubMed ID: 17591444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
    Zhang MZ; Xu J; Yao B; Yin H; Cai Q; Shrubsole MJ; Chen X; Kon V; Zheng W; Pozzi A; Harris RC
    J Clin Invest; 2009 Apr; 119(4):876-85. PubMed ID: 19307727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
    Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
    J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the gatekeepers of glucocorticoids for chemoprevention of non-melanoma skin cancer.
    Mancha-Ramirez AM; Yang X; Liang H; Junco J; Lee KP; Bovio SF; Espinoza M; Wool J; Slaga A; Glade DC; Hanes M; Malik G; Kim DJ; DiGiovanni J; Slaga TJ
    Mol Carcinog; 2019 Jan; 58(1):102-112. PubMed ID: 30302860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.